183 related articles for article (PubMed ID: 9334913)
1. Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus.
Schnell O; Muhr D; Weiss M; Kirsch CM; Haslbeck M; Tatsch K; Standl E
J Diabetes Complications; 1997; 11(5):307-13. PubMed ID: 9334913
[TBL] [Abstract][Full Text] [Related]
2. Scintigraphically assessed cardiac sympathetic dysinnervation in poorly controlled type 1 diabetes mellitus: one-year follow-up with improved metabolic control.
Muhr-Becker D; Weiss M; Tatsch K; Wolfram G; Standl E; Schnell O
Exp Clin Endocrinol Diabetes; 1999; 107(5):306-12. PubMed ID: 10482043
[TBL] [Abstract][Full Text] [Related]
3. Partial restoration of scintigraphically assessed cardiac sympathetic denervation in newly diagnosed patients with insulin-dependent (type 1) diabetes mellitus at one-year follow-up.
Schnell O; Muhr D; Dresel S; Weiss M; Haslbeck M; Standl E
Diabet Med; 1997 Jan; 14(1):57-62. PubMed ID: 9017355
[TBL] [Abstract][Full Text] [Related]
4. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
D'Alto M; Maurea S; Basso A; Varrella P; Polverino W; Bianchi U; Bonelli A; Salvatore M; Chiariello M
Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590
[TBL] [Abstract][Full Text] [Related]
5. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy.
Schnell O; Kirsch CM; Stemplinger J; Haslbeck M; Standl E
Diabetologia; 1995 Nov; 38(11):1345-52. PubMed ID: 8582545
[TBL] [Abstract][Full Text] [Related]
6. Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients.
Schnell O; Muhr D; Weiss M; Dresel S; Haslbeck M; Standl E
Diabetes; 1996 Jun; 45(6):801-5. PubMed ID: 8635656
[TBL] [Abstract][Full Text] [Related]
7. Cardiac sympathetic dysinnervation in Type 2 diabetes mellitus with and without ECG-based cardiac autonomic neuropathy.
Schnell O; Hammer K; Muhr-Becker D; Ziegler A; Weiss M; Tatsch K; Standl E
J Diabetes Complications; 2002; 16(3):220-7. PubMed ID: 12015192
[TBL] [Abstract][Full Text] [Related]
8. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
Langer A; Freeman MR; Josse RG; Armstrong PW
J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM.
Turpeinen AK; Vanninen E; Kuikka JT; Uusitupa MI
Diabetes Care; 1996 Oct; 19(10):1083-90. PubMed ID: 8886553
[TBL] [Abstract][Full Text] [Related]
10. Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients.
Ziegler D; Weise F; Langen KJ; Piolot R; Boy C; Hübinger A; Müller-Gärtner HW; Gries FA
Diabetologia; 1998 Apr; 41(4):443-51. PubMed ID: 9562349
[TBL] [Abstract][Full Text] [Related]
11. QTc interval and scintigraphically assessed myocardial perfusion in newly diagnosed and long-term type 1 diabetes mellitus.
Meier M; Muhr D; Weiss M; Tatsch K; Standl E; Schnell O
J Diabetes Complications; 2000; 14(2):90-5. PubMed ID: 10959071
[TBL] [Abstract][Full Text] [Related]
12. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy.
Miranda CH; Figueiredo AB; Maciel BC; Marin-Neto JA; Simões MV
J Nucl Med; 2011 Apr; 52(4):504-10. PubMed ID: 21441532
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients.
Schsnell O; Muhr D; Dresel S; Tatsch K; Ziegler AG; Haslbeck M; Standl E
Diabetologia; 1996 Aug; 39(8):970-5. PubMed ID: 8858220
[TBL] [Abstract][Full Text] [Related]
14. Sympathetic reinnervation after acute myocardial infarction.
Hartikainen J; Kuikka J; Mäntysaari M; Länsimies E; Pyörälä K
Am J Cardiol; 1996 Jan; 77(1):5-9. PubMed ID: 8540457
[TBL] [Abstract][Full Text] [Related]
15. Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities.
Parthenakis FI; Prassopoulos VK; Koukouraki SI; Zacharis EA; Diakakis GF; Karkavitsas NK; Vardas PE
J Nucl Cardiol; 2002; 9(1):15-22. PubMed ID: 11845125
[TBL] [Abstract][Full Text] [Related]
16. Use of iodine-123 metaiodobenzylguanidine scintigraphy to assess cardiac sympathetic denervation and the impact of hypertension in patients with non-insulin-dependent diabetes mellitus.
Tamura K; Utsunomiya K; Nakatani Y; Saika Y; Onishi S; Iwasaka T
Eur J Nucl Med; 1999 Oct; 26(10):1310-6. PubMed ID: 10541830
[TBL] [Abstract][Full Text] [Related]
17. Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function.
Kreiner G; Wolzt M; Fasching P; Leitha T; Edlmayer A; Korn A; Waldhäusl W; Dudczak R
Diabetes; 1995 May; 44(5):543-9. PubMed ID: 7729613
[TBL] [Abstract][Full Text] [Related]
18. Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease.
Simula S; Vanninen E; Viitanen L; Kareinen A; Lehto S; Pajunen P; Syvänne M; Kuikka J; Laakso M; Hartikainen J
J Nucl Med; 2002 Jan; 43(1):1-7. PubMed ID: 11801695
[TBL] [Abstract][Full Text] [Related]
19. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy.
Sacre JW; Franjic B; Coombes JS; Marwick TH; Baumert M
J Cardiovasc Electrophysiol; 2013 Mar; 24(3):305-13. PubMed ID: 23210722
[TBL] [Abstract][Full Text] [Related]
20. No difference in cardiac innervation of diabetic patients with painful and asymptomatic coronary artery disease.
Koistinen MJ; Airaksinen KE; Huikuri HV; Linnaluoto MM; Heikkila J; Torniainen P; Ahonen A
Diabetes Care; 1996 Mar; 19(3):231-3. PubMed ID: 8742567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
